These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 30387134)

  • 1. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer.
    Zhao J; Xue Y; Pan Y; Yao A; Wang G; Li D; Wang T; Zhao S; Hou Y
    J Cell Physiol; 2019 May; 234(5):7051-7061. PubMed ID: 30387134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
    Jiang Q; Wei H; Tian Z
    BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells.
    Bernardo AR; Cosgaya JM; Aranda A; Jiménez-Lara AM
    Cell Death Dis; 2013 Jan; 4(1):e479. PubMed ID: 23370279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness.
    Bugge M; Bergstrom B; Eide OK; Solli H; Kjønstad IF; Stenvik J; Espevik T; Nilsen NJ
    J Biol Chem; 2017 Sep; 292(37):15408-15425. PubMed ID: 28717003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis.
    Hu Y; Zhang K; Zhu X; Zheng X; Wang C; Niu X; Jiang T; Ji X; Zhao W; Pang L; Qi Y; Li F; Li L; Xu Z; Gu W; Zou H
    Int J Nanomedicine; 2021; 16():2173-2186. PubMed ID: 33758505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells.
    Kumar A; Zhang J; Yu FS
    Immunology; 2006 Jan; 117(1):11-21. PubMed ID: 16423036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid Administration.
    Nocera DA; Roselli E; Araya P; Nuñez NG; Lienenklaus S; Jablonska J; Weiss S; Gatti G; Brinkmann MM; Kröger A; Morón G; Maccioni M
    J Immunol; 2016 Mar; 196(6):2860-9. PubMed ID: 26880763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis.
    Taura M; Fukuda R; Suico MA; Eguma A; Koga T; Shuto T; Sato T; Morino-Koga S; Kai H
    Cancer Sci; 2010 Jul; 101(7):1610-7. PubMed ID: 20367642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporally designed treatment of melanoma cells by ATRA and polyI: C results in enhanced chemokine and IFNβ secretion controlled differently by TLR3 and MDA5.
    Szabo A; Osman RM; Bacskai I; Kumar BV; Agod Z; Lanyi A; Gogolak P; Rajnavolgyi E
    Melanoma Res; 2012 Oct; 22(5):351-61. PubMed ID: 22797253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.
    Galli R; Paone A; Fabbri M; Zanesi N; Calore F; Cascione L; Acunzo M; Stoppacciaro A; Tubaro A; Lovat F; Gasparini P; Fadda P; Alder H; Volinia S; Filippini A; Ziparo E; Riccioli A; Croce CM
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9812-7. PubMed ID: 23716670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Poly I:C in inducing growth inhibition and apoptosis of human hepatocellular carcinoma cells].
    Shen P; Jiang TW; Lu HQ; Zhang LZ; Han HX; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):525-7. PubMed ID: 19304544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
    Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
    Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner.
    Chiba Y; Mizoguchi I; Mitobe K; Higuchi K; Nagai H; Nishigori C; Mizuguchi J; Yoshimoto T
    PLoS One; 2013; 8(10):e76159. PubMed ID: 24155891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 3 activation in retinal pigment epithelium cells - Mitogen-activated protein kinase pathways of cell death and vascular endothelial growth factor secretion.
    Klettner A; Koinzer S; Meyer T; Roider J
    Acta Ophthalmol; 2013 May; 91(3):e211-8. PubMed ID: 23387336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 3 ligand-induced antiviral response in mouse osteoblastic cells.
    Nakamura K; Deyama Y; Yoshimura Y; Suzuki K; Morita M
    Int J Mol Med; 2007 May; 19(5):771-5. PubMed ID: 17390082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.
    Jeong JY; Kim KS; Moon JS; Song JA; Choi SH; Kim KI; Kim TH; An HJ
    Apoptosis; 2013 Apr; 18(4):509-20. PubMed ID: 23371322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Toll-like receptor 3 induces apoptosis of oral squamous carcinoma cells in vitro and in vivo.
    Luo Q; Hu S; Yan M; Sun Z; Chen W; Chen F
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1266-75. PubMed ID: 22568929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
    Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
    Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.